SEC Tracker
Get the app

Oruka Therapeutics ORKA

Lawrence Otto Klein (CEO) sold 25,000 ORKA at $95.60, worth $2.4M, under a 10b5-1 plan

Form
4
Filed
Importance
Routine
  1. 25,000 shares acquired at $7.8
  2. 6,466 shares sold at $94.77
  3. 15,036 shares sold at $95.64
  4. 2,442 shares sold at $96.70

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Oruka Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. CytomX Therapeutics CTMX public float $372M, Jun 30, 2025
  2. Cronos Group CRON public float $380M, Jun 30, 2025
  3. REGENXBIO RGNX public float $385M, Jun 30, 2025
  4. Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
  5. Cryoport CYRX public float $400M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.